Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Subarachnoid Hemorrhage 1Seizures 1Meningitis 1Ischemic Stroke 1Heart Arrest 1Brain Neoplasms 1Brain Injuries, Traumatic 1Brain Injuries 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2330Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1782Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 935Prednisone 925Cetuximab 921Lenalidomide 916Trastuzumab 901

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Airway Extubation × Clear all
NCT02920580 2020-02-05

NEURO-ETT

Sunnybrook Health Sciences Centre

Phase NA Unknown
27 enrolled
CNS

Brain Injuries, Traumatic, Ischemic Stroke, Brain Injuries, Brain Neoplasms, Heart Arrest, Meningitis, Seizures, Subarachnoid Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡